Moreover, AT1R deficiency or treatment with ARBs prevented the diabetes-induced hyperactivation of the ligand/RAGE axis and monocyte chemoattractant protein (MCP)-1-related inflammation, and atherogenesis in diabetic mice [95]. This evidence concerns the gene AGTR1 and diabetes mellitus.